Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1971 1
1972 3
1973 2
1974 2
1975 4
1976 2
1977 12
1978 4
1979 10
1980 4
1981 8
1982 15
1983 8
1984 9
1985 6
1986 4
1987 14
1988 15
1989 5
1990 7
1991 11
1992 9
1993 5
1994 9
1995 8
1996 7
1997 14
1998 9
1999 7
2000 7
2001 7
2002 14
2003 10
2004 11
2005 12
2006 16
2007 11
2008 20
2009 24
2010 25
2011 22
2012 20
2013 18
2014 16
2015 25
2016 22
2017 18
2018 24
2019 22
2020 22
2021 22
2022 24
2023 19
2024 13
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

632 results

Results by year

Filters applied: . Clear all
Page 1
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators. Tashkin DP, et al. Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25. Lancet Respir Med. 2016. PMID: 27469583 Free PMC article. Clinical Trial.
Marijuana and Lung Disease.
Tashkin DP. Tashkin DP. Chest. 2018 Sep;154(3):653-663. doi: 10.1016/j.chest.2018.05.005. Epub 2018 May 17. Chest. 2018. PMID: 29778658 Review.
Pulmonary effects of inhaled cannabis smoke.
Tashkin DP, Roth MD. Tashkin DP, et al. Am J Drug Alcohol Abuse. 2019;45(6):596-609. doi: 10.1080/00952990.2019.1627366. Epub 2019 Jul 12. Am J Drug Alcohol Abuse. 2019. PMID: 31298945 Review.
Inhaled Marijuana and the Lung.
Tashkin DP, Tan WC. Tashkin DP, et al. J Allergy Clin Immunol Pract. 2022 Nov;10(11):2822-2829. doi: 10.1016/j.jaip.2022.05.009. Epub 2022 May 21. J Allergy Clin Immunol Pract. 2022. PMID: 35609784
Impact of Marijuana Use on Lung Health.
Bando JM, Tashkin DP, Barjaktarevic IZ. Bando JM, et al. Among authors: tashkin dp. Semin Respir Crit Care Med. 2024 Oct;45(5):548-559. doi: 10.1055/s-0044-1785679. Epub 2024 Jul 5. Semin Respir Crit Care Med. 2024. PMID: 38968961 Free article. Review.
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease.
Bae SS, Abtin F, Kim G, Markovic D, Chan C, Moghadam-Kia S, Oddis CV, Sullivan D, Marder G, Venuturupalli S, Dellaripa PF, Doyle TJ, Hunninghake GM, Falk J, Charles-Schoeman C, Tashkin DP, Goldin J, Aggarwal R. Bae SS, et al. Among authors: tashkin dp. RMD Open. 2024 Nov 27;10(4):e004592. doi: 10.1136/rmdopen-2024-004592. RMD Open. 2024. PMID: 39608864 Free PMC article.
632 results